Outlook Therapeutics
OTLK
#9567
Rank
โ‚น4.32 B
Marketcap
โ‚น135.21
Share price
-4.88%
Change (1 day)
-81.42%
Change (1 year)

Revenue for Outlook Therapeutics (OTLK)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Outlook Therapeutics from 2015 to 2024

201620192022โ‚น0.1Bโ‚น0.2Bโ‚น0.3Bโ‚น0.4Bโ‚น0.5Bโ‚น0.6B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A-100%
2019 โ‚น0.50 B113.38%
2018 โ‚น0.23 B-13.44%
2017 โ‚น0.27 B75.79%
2016 โ‚น0.15 B-28.67%
2015 โ‚น0.21 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น50.07 BN/A Jersey
โ‚น73.43 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น8.92 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.89 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK